Maternal serum total activin A and follistatin in pregnancy and parturition

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 107, Issue 8, 2000, Pages 995-1000

  Schneider Kolsky, Michal ^a   D’antona, Donato ^a   Evans, Lee W ^b   Taylor, Nancy ^a   O’connor, Anne ^a   Groome, Nigel P ^b   De Kretser, David ^a   Wallace, Euan M ^a  

^a MONASH UNIVERSITY   (Australia)

^b OXFORD BROOKES UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; FOLLISTATIN;

ARTICLE; BLOOD LEVEL; CESAREAN SECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LABOR; LABOR INDUCTION; MATERNAL SERUM; NORMAL HUMAN; PREGNANCY; PRIORITY JOURNAL;

ACTIVINS; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLISTATIN; GLYCOPROTEINS; GROWTH SUBSTANCES; HUMANS; INHIBINS; LABOR ONSET; LONGITUDINAL STUDIES; PREGNANCY; PREGNANCY TRIMESTER, THIRD;

EID: 0033915064     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2000.tb10402.x     Document Type: Article

References (32)

1. Ling N, Ying SY, Ueno N. Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature 1986; 321: 779-782.
2. Ueno N, Nishimatsu S, Murakami K. Activin as a cell-differentiation factor. Growth Factor Res 1990; 2: 113-124.
3. Ying SY, Inhibins activins and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev. 1988; 9: 267-293.
4. Wallace EM, Healy DL. Inhibins and activins: roles in clinical practice. Br J Obstet Gynaecol 1996; 103:945-956.
5. Petraglia F, Garuti G, Calza L et al. Inhibin subunit in human placenta: localization and messenger ribonucleic acid levels during pregnancy. Am J Obstet Gynecol 1991; 165: 750-758.
6. Petraglia F, Garg S, Florio P et al. Activin A and activin B measured in maternal serum, cord blood serum, and amniotic fluid during human pregnancy. Endocr J; 1993; 1: 323-327.
7. Qu J, Thomas K. Inhibin and activin production in human placenta. Endocr Rev 1995; 16: 485-507.
8. Riley SC, Balfour CM Wathen N et al. Follistatin and activin A in extra-embryonic coelomic and amniotic fluids and maternal serum in early pregnancy. Hum Reprod 1998; 13: 2624-2628.
9. Fowler PA, Evans LW, Groome NP, Templeton A, Knight PG. A longitudinal study of maternal serum inhibin A, inhibin B, activin A, activin AB, pro-αC and follistatin during pregnancy. Hum Reprod 1998; 13: 3530-3536.
10. Petraglia F, Gallinelli A, De Vita D, Lewis K, Methers L, Vale W. Activin at parturition: changes of maternal serum levels and evidence for binding sites in placenta and fetal membranes. Obstet Gynecol 1994; 84: 278-282.
11. Woodruff TK, Sluss P, Wang E, Janssen I, Mersol-Barg MS. Activin A and follistatin are dynamically regulated during human pregnancy. J Endocrinol 1997; 152:167-174.
12. O'Connor AE, McFarlane JR, Hayward S, Yohkaichiya T, Groome NP, de Kretser DM. Serum activin A and follistatin concentrations during human pregnancy: a cross sectional and longitudinal study. Hum Reprod 1999; 14: 827-832.
13. Petraglia F, Di Blasio AM, Florio P et al. High levels of fetal membrane activin βA and activin IIB mRNA's and augmented concentration of amniotic fluid activin A in women in term and preterm labor. J Endocrinol 1997; 154:95-101.
14. Petraglia F, Anceschi M, Calza L et al. Inhibin and activin in human fetal membranes: evidence for a local effect on prostaglandin release. J Clin Endocrinol Metab 1993; 77: 542-548.
15. Knight PG, Muttukrishna S, Groome NP. Development and application of a two-site enzyme immunoassay for the determination of ‘total’ activin-A concentrations in serum and follicular fluid. J Endocrinol 1996; 148: 2667-2679.
16. Evans LW, Muttukrishna S, Groome NP. Development, validation and application of an ultra-sensitive two-site enzyme immunoassay for total human follistatin in biological fluids. J Endocrinol 1998; 98: 275-282.
17. Petraglia F, Sawchenko P, Lim ATW, Rivier LJ, Vale W. Localization, secretion, and action of inhibin in human placenta. Science 1987; 237: 187-189.
18. Petraglia F, Calza L, Garuti GC et al. Presence and synthesis of inhibin subunits in human decidua. J. Clin Endocrinol Metab 1990; 71:487-492.
19. Minami S, Yamoto M, Nakano R. Immunohistochemical localization of inhibin/activin subunits in human placenta. Obstet Gynecol 1992; 80:410-414.
20. Florio P, Benedetto C, Luisi S et al. Activin A, inhibin A, inhibin B and parturition: changes of maternal and cord serum levels according to the mode of delivery. Br J Obstet Gynaecol 1999; 106: 1061-1065.
21. Muttukrishna S, Child TJ, Groome NP, Ledger WL. Source of circulating levels of inhibin A, pro alpha C-containing inhibins and activin A in early pregnancy. Hum Reprod 1997; 12: 1089-1093.
22. Shimonaka M, Inouye S, Shimasaki S, Ling N. Follistatin binds to both activin and inhibin through the common beta-subunit. Endocrinology 1991; 128: 3313-3315.
23. McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placen-tal clock controlling the length of human pregnancy. Nat med 1995; 1: 460-463.
24. Wakatsuki M, Shintani Y, Abe M, Liu Z-H, Shitsukawa K, Saito S. Immunoradiometric assay for follistatin: serum immunoreactive follistatin levels in normal adults and pregnant women. J Clin Endocrinol Metab 1996; 81: 630-634.
25. Vaughan JM, Vale WW. Alpha 2-macroglobulin is a binding protein of inhibin and activin. Endocrinology 1993; 132: 2038-2050.
26. Boxmeyer HE, Lu L, Cooper S, Schwall RH, Mason AJ, Nikolics K. Selective and indirect modulation of human multipotential and erythroid hematopoietic progenitor cell proliferation by recombinant human activin and inhibin. Proc Natl Acad Sci USA 1988; 85: 9052-9056.
27. Yu J, Shao L, Vaughan J, Vale W, Yu AL. Characterization of the potentiation effect of activin on human erythroid colony formation in vitro. Blood 1989; 73:952-960.
28. Ward J, Wallace EM, Hooper SB, Jenkin G. Activin A: a novel marker of fetal wellbeing? [abstract]. Proceedings of the 3rd Annual Congress of The Perinatal Society of Australia and New Zealand, Melbourne, March 1999: 145.
29. Gregg AR, Weiner CP. ‘Normal’ umbilical arterial and venous blood gas values. Clin Obstet Gynecol 1993; 36: 24-32.
30. Ramin SM, Gilstrap LC, Leveno KJ, Burris J, Little BB. Umbilical artery acid-base status in the preterm infant. Obstet Gynecol 1989; 74: 256-258.
31. Petraglia F, de Vita D, Gallinelli A et al. Abnormal concentration of maternal serum activin-A in gestational diseases. J Clin Endocrinol Metab 1995; 80: 558-561.
32. Muttukrishna S, Knight PG, Groome NP, Redman CWG, Ledger WL. Activin A and inhibin A as possible endocrine markers for pre-eclampsia. Lancet 1997; 349: 1285-1288.